News & Events

< Back to News Overview

Celladon Corporation Announces Pre-clinical Study Demonstrating Inhalable MYDICAR reverse PAH

30 / 07 / 2013

Please see the attached document(s) below.

Downloads

Download "Celladon announces pre- clincal study" [22B]